GlycoMar is an early stage discovery company, supplying marine-derived glycobiology compounds to the biopharmaceutical industry and developing novel cosmeceutical and nutraceutical ingredients.
We isolate, characterise and screen these compounds in a range of anti-inflammatory assays, with leads being further developed in-house, or offered for licensing.
GlycoMar's subsidiary company VeroMara provides analytical services to the seafood and aquaculture industries.